MTOR and nonpapillary renal cell carcinoma: 9p loss, which includes the tumor suppressor CDKN2A, was associated with upregulation of translation initiation, mTOR and MYC signaling, consistent with loss of CDKN2A and MYC activation previously reported in ccRCC progression (Bailey et al., 2017).